<DOC>
	<DOC>NCT02841761</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of ACT-132577 on the pharmacokinetics of midazolam and 1-hydroxy midazolam and to evaluate the safety and tolerability of ACT-132577 when administered alone and in combination with midazolam.</brief_summary>
	<brief_title>A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>Signed informed consent in the local language prior to any studymandated procedure Body mass index (BMI) of 18.0 to 30.0 kg/m2 (inclusive) at screening Healthy on the basis of medical history, physical examination, cardiovascular assessments and serology and laboratory tests Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>